Diamant Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Diamant Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,700	Closed	-$232K	–	79
2019 Q1	$232K	Sell	3,700 -1,200	-24%	-$82.4K	0.23%	70
2018 Q4	$293K	Sell	4,900 -350	-7%	-$21K	0.33%	61
2018 Q3	$338K	Sell	5,250 -3,100	-37%	-$173K	0.31%	64
2018 Q2	$376K	Hold	8,350	–	–	0.36%	55
2018 Q1	$259K	Buy	8,350 +900	+12%	+$29.6K	0.25%	68
2017 Q4	$223	Buy	+7,450	New	+$216K	0.03%	76

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Diamant Asset Management's BEAT Position: Q2 2019 in Review

Diamant Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 3,700 shares — an estimated $232K sold.

Diamant Asset Management first reported a position in BEAT in Q4 2017 and held it in 6 quarters. The position peaked at $376K in Q2 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Diamant Asset Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Diamant Asset Management sold 3,700 BioTelemetry, Inc. shares in Q2 2019, an estimated $232K.
Diamant Asset Management first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 6 quarters.
Diamant Asset Management's BioTelemetry, Inc. position peaked at $376K in Q2 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Diamant Asset Management's 13F filing for Q2 2019, filed 22 Jul 2019.